<--- Back to Details
First PageDocument Content
Chemistry / Intravenous fluids / Organochlorides / Diabetes / Insulin aspart / Infusion pump / Intravenous therapy / Lorazepam / Treprostinil / Medicine / Pharmacology / Dosage forms
Date: 2014-12-03 13:04:55
Chemistry
Intravenous fluids
Organochlorides
Diabetes
Insulin aspart
Infusion pump
Intravenous therapy
Lorazepam
Treprostinil
Medicine
Pharmacology
Dosage forms

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BLINCYTOTM safely and effectively. See full prescribing information for BLINCYTO. BLINCYTO (blinatumomab) for inject

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 620,89 KB

Share Document on Facebook

Similar Documents

California Naturopathic Medicine Committee - Intravenous Therapy Approved Providers

California Naturopathic Medicine Committee - Intravenous Therapy Approved Providers

DocID: 1tWfs - View Document

FOR IMMEDIATE RELEASE  FDA Approves Carnexiv™ (carbamazepine) injection as Intravenous Short-Term Replacement Therapy for Certain Seizure Types Carnexiv is the first FDA-approved intravenous carbamazepine option Health

FOR IMMEDIATE RELEASE FDA Approves Carnexiv™ (carbamazepine) injection as Intravenous Short-Term Replacement Therapy for Certain Seizure Types Carnexiv is the first FDA-approved intravenous carbamazepine option Health

DocID: 1taCQ - View Document

Intravenous	
  infusion	
  practice	
  as	
  a	
   complex	
  cognitive	
  system:	
  Exploring	
   layers	
  of	
  Distributed	
  Cognition	
   Dominic	
  Furniss 1 ,	
  Imogen	
  Lyons 1 ,	
  Bryony

Intravenous  infusion  practice  as  a   complex  cognitive  system:  Exploring   layers  of  Distributed  Cognition   Dominic  Furniss 1 ,  Imogen  Lyons 1 ,  Bryony

DocID: 1rhqf - View Document

Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform

Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform

DocID: 1reFq - View Document

Fresenius Kabi USA, LLC Three Corporate Drive Lake Zurich, IllinoisTTwww.fresenius-kabi.us

Fresenius Kabi USA, LLC Three Corporate Drive Lake Zurich, IllinoisTTwww.fresenius-kabi.us

DocID: 1r4t7 - View Document